Successful co-treatment with LHRH-agonist for ovarian over-stimulation and cystic formation in premenopausal tamoxifen exposure (Q78244539)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10481939 AND SRC:MED&resulttype=core&format=json

12 December 2019

title

Successful co-treatment with LHRH-agonist for ovarian over-stimulation and cystic formation in premenopausal tamoxifen exposure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10481939 AND SRC:MED&resulttype=core&format=json

12 December 2019

1 reference

I Cohen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10481939 AND SRC:MED&resulttype=core&format=json

12 December 2019

R Tepper

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10481939 AND SRC:MED&resulttype=core&format=json

12 December 2019

A Figer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10481939 AND SRC:MED&resulttype=core&format=json

12 December 2019

D Flex

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10481939 AND SRC:MED&resulttype=core&format=json

12 December 2019

J Shapira

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10481939 AND SRC:MED&resulttype=core&format=json

12 December 2019

Y Beyth

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10481939 AND SRC:MED&resulttype=core&format=json

12 December 2019

publication date

1 May 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10481939 AND SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

12 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10481939 AND SRC:MED&resulttype=core&format=json

12 December 2019

volume

55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10481939 AND SRC:MED&resulttype=core&format=json

12 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10481939 AND SRC:MED&resulttype=core&format=json

12 December 2019

page(s)

119-125

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10481939 AND SRC:MED&resulttype=core&format=json

Gynecologic complications associated with long-term adjuvant tamoxifen therapy for breast cancer

12 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1023/A:1006184028515

7 January 2021

Effect of the anti-oestrogen tamoxifen on plasma levels of luteinizing hormone, follicle-stimulating hormone, prolactin, oestradiol and progesterone in normal pre-menopausal women

1 reference

https://api.crossref.org/works/10.1023/A:1006184028515

7 January 2021

Ovarian cyst formation in two pre-menopausal patients treated with tamoxifen for breast cancer

1 reference

https://api.crossref.org/works/10.1023/A:1006184028515

7 January 2021

Tamoxifen treatment in premenopausal breast cancer patients may be associated with ovarian overstimulation, cystic formations and fibroid overgrowth

1 reference

https://api.crossref.org/works/10.1023/A:1006184028515

7 January 2021

Adjuvant antiestrogen therapy for breast cancer. Past, present, and future.

1 reference

https://api.crossref.org/works/10.1023/A:1006184028515

7 January 2021

Population-Based Study of Tamoxifen Therapy and Subsequent Ovarian, Endometrial, and Breast Cancers

1 reference

https://api.crossref.org/works/10.1023/A:1006184028515

7 January 2021

Results of the Cancer Research Campaign Adjuvant Trial for Perioperative Cyclophosphamide and Long-Term Tamoxifen in Early Breast Cancer reported at the tenth year of follow-up. Cancer Research Campaign Breast Cancer Trials Group

1 reference

https://api.crossref.org/works/10.1023/A:1006184028515

7 January 2021

The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancer

1 reference

https://api.crossref.org/works/10.1023/A:1006184028515

7 January 2021

Endocrine treatment of breast cancer in women

1 reference

https://api.crossref.org/works/10.1023/A:1006184028515

7 January 2021

LH-RH agonists in the treatment of premenopausal patients with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023/A:1006184028515

7 January 2021

Medical Castration with Zoladex: A Conservative Approach to Premenopausal Breast Cancer

1 reference

https://api.crossref.org/works/10.1023/A:1006184028515

7 January 2021

Strength-duration characteristics of estrogen effects on gonadotropin response to gonadotropin-releasing hormone in women. II. Effects of varying concentrations of estradiol

1 reference

https://api.crossref.org/works/10.1023/A:1006184028515

7 January 2021

Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.

1 reference

https://api.crossref.org/works/10.1023/A:1006184028515

7 January 2021

Alteration of endocrine parameters in premenopausal women with breast cancer during long-term adjuvant therapy with tamoxifen as the single agent

1 reference

https://api.crossref.org/works/10.1023/A:1006184028515

7 January 2021

Tamoxifen in premenopausal patients with metastatic breast cancer: a review

1 reference

https://api.crossref.org/works/10.1023/A:1006184028515

7 January 2021

8th San Antonio Breast Cancer Symposium--Plenary lecture. Autocrine and paracrine growth regulation of human breast cancer

1 reference

https://api.crossref.org/works/10.1023/A:1006184028515

7 January 2021

Reversible control of oestradiol-stimulated growth of MCF-7 tumours by tamoxifen in the athymic mouse

1 reference

https://api.crossref.org/works/10.1023/A:1006184028515

7 January 2021

The pharmacology and clinical uses of tamoxifen

1 reference

https://api.crossref.org/works/10.1023/A:1006184028515

7 January 2021

Ovarian torsion in a premenopausal woman treated with tamoxifen for breast cancer

1 reference

https://api.crossref.org/works/10.1023/A:1006184028515

7 January 2021

Ovarian cysts in tamoxifen-treated premenopausal women with breast cancer--a management dilemma

1 reference

https://api.crossref.org/works/10.1023/A:1006184028515

7 January 2021

Ovarian cysts in premenopausal and postmenopausal tamoxifen-treated women with breast cancer

1 reference

https://api.crossref.org/works/10.1023/A:1006184028515

7 January 2021

Ovarian cancer and long-term tamoxifen in premenopausal women

1 reference

https://api.crossref.org/works/10.1023/A:1006184028515

7 January 2021

Rapid growth of leiomyoma in patient receiving tamoxifen

1 reference

https://api.crossref.org/works/10.1023/A:1006184028515

7 January 2021

Effects of nafarelin on bone density

1 reference

https://api.crossref.org/works/10.1023/A:1006184028515

7 January 2021

Leuprolide acetate and bone mineral density measured by quantitative digitized radiography

1 reference

https://api.crossref.org/works/10.1023/A:1006184028515

7 January 2021

Hormone replacement therapy in breast cancer survivors: a cohort study

1 reference

https://api.crossref.org/works/10.1023/A:1006184028515

7 January 2021

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1023/A:1006184028515

7 January 2021